These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16791397)

  • 1. The oxalate level in ultrafiltrate fluid collected from a dialyzer is useful for estimating the plasma oxalate level in hemodialysis patients.
    Ogi M; Abe R; Nishitani T; Wakabayashi M; Wakabayashi T
    Clin Exp Nephrol; 2006 Jun; 10(2):118-23. PubMed ID: 16791397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients.
    Canavese C; Petrarulo M; Massarenti P; Berutti S; Fenoglio R; Pauletto D; Lanfranco G; Bergamo D; Sandri L; Marangella M
    Am J Kidney Dis; 2005 Mar; 45(3):540-9. PubMed ID: 15754276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of intravenous ascorbic acid versus intravenous iron for functional iron deficiency in hemodialysis patients].
    Ogi M; Horiuchi T; Abe R; Wakabayashi M; Wakabayashi T
    Nihon Jinzo Gakkai Shi; 2004; 46(8):804-9. PubMed ID: 15645737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia.
    Tarng DC; Wei YH; Huang TP; Kuo BI; Yang WC
    Kidney Int; 1999 Jun; 55(6):2477-86. PubMed ID: 10354297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N; Osman-Malik Y; Frinak S; Besarab A
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary hyperoxalemia caused by vitamin C supplementation in regular hemodialysis patients.
    Ono K
    Clin Nephrol; 1986 Nov; 26(5):239-43. PubMed ID: 3802587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference-free sample preparation for the determination of plasma oxalate analyzed by HPLC-ER: preliminary results from calcium oxalate stone-formers and non-stone-formers.
    Hönow R; Simon A; Hesse A
    Clin Chim Acta; 2002 Apr; 318(1-2):19-24. PubMed ID: 11880108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial hematologic effects of daily oral ascorbic acid therapy in ESRD patients with anemia and abnormal iron homeostasis: a preliminary study.
    Sirover WD; Siddiqui AA; Benz RL
    Ren Fail; 2008; 30(9):884-9. PubMed ID: 18925528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamins and quality of life in hemodialysis patients.
    Mydlik M; Derzsiová K
    J Nephrol; 2008; 21 Suppl 13():S129-33. PubMed ID: 18446746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: a clinical trial.
    Giancaspro V; Nuzziello M; Pallotta G; Sacchetti A; Petrarulo F
    J Nephrol; 2000; 13(6):444-9. PubMed ID: 11132761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma profiles and dialysis kinetics of oxalate in patients receiving hemodialysis.
    Marangella M; Petrarulo M; Mandolfo S; Vitale C; Cosseddu D; Linari F
    Nephron; 1992; 60(1):74-80. PubMed ID: 1738418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of oxalate in human plasma ultrafiltrate by ion chromatography.
    Manoharan M; Schwille PO
    J Chromatogr B Biomed Sci Appl; 1997 Oct; 700(1-2):261-8. PubMed ID: 9390738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of plasma oxalate in healthy subjects and in patients with chronic renal failure using immobilised oxalate oxidase.
    Kasidas GP; Rose GA
    Clin Chim Acta; 1986 Jan; 154(1):49-58. PubMed ID: 3943224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study.
    Ogawa C; Tsuchiya K; Tomosugi N; Kanda F; Maeda K; Maeda T
    PLoS One; 2017; 12(6):e0179608. PubMed ID: 28662118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple, rapid assay for plasma oxalate in uraemic patients using oxalate oxidase, which is free from vitamin C interference.
    Rolton HA; McConnell KN; Modi KS; Macdougall AI
    Clin Chim Acta; 1989 Jul; 182(3):247-54. PubMed ID: 2766549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Kinetics of oxalate in hemodialysis].
    Marangella M; Petrarulo M; Vitale C; Cosseddu D; Linari F
    Minerva Urol Nefrol; 1991; 43(3):165-9. PubMed ID: 1817340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
    Riedel MK; Morgenstern T
    Dtsch Med Wochenschr; 2004 Sep; 129(36):1849-53. PubMed ID: 15368155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure.
    Hoppe B; Kemper MJ; Bökenkamp A; Portale AA; Cohn RA; Langman CB
    Kidney Int; 1999 Jul; 56(1):268-74. PubMed ID: 10411702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major factors modulating the serum oxalic acid level in hemodialysis patients.
    Ogawa Y; Machida N; Jahana M; Gakiya M; Chinen Y; Oda M; Morozumi M; Sugaya K
    Front Biosci; 2004 Sep; 9():2901-8. PubMed ID: 15353324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.